The American Diabetes Association[1]’s (ADA’s) Chief Scientific, Medical and Mission Officer, William T. Cefalu, MD, JDRF Chief Mission Officer, Aaron Kowlaski[2] and other prominent diabetes advocates testified before the U.S. House of Representatives Committee on Energy & Commerce’s Oversight and Investigations Subcommittee today. The topic, “Priced Out of a Lifesaving Drug: The Human Impact of Rising Insulin Prices” addressed the rising costs of insulin[3], which impact millions of Americans with diabetes who rely on this life-sustaining medication. Watch the hearings here[4].
Source URL: https://www.diabetesselfmanagement.com/blog/u-s-congress-holds-hearings-on-insulin-costs/
Maureen McCarthy: Maureen McCarthy is the former Editorial Director, Wellness.
Disclaimer of Medical Advice: Statements and opinions expressed on this Web site are those of the authors and not necessarily those of the publishers or advertisers. The information, which comes from qualified medical writers, does not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs.
Copyright ©2024 Diabetes Self-Management unless otherwise noted.